1. Home
  2. CTMX vs NNDM Comparison

CTMX vs NNDM Comparison

Compare CTMX & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • NNDM
  • Stock Information
  • Founded
  • CTMX 2008
  • NNDM 2012
  • Country
  • CTMX United States
  • NNDM United States
  • Employees
  • CTMX N/A
  • NNDM N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • NNDM Electrical Products
  • Sector
  • CTMX Health Care
  • NNDM Technology
  • Exchange
  • CTMX Nasdaq
  • NNDM Nasdaq
  • Market Cap
  • CTMX 349.6M
  • NNDM 334.6M
  • IPO Year
  • CTMX 2015
  • NNDM N/A
  • Fundamental
  • Price
  • CTMX $2.13
  • NNDM $1.38
  • Analyst Decision
  • CTMX Strong Buy
  • NNDM
  • Analyst Count
  • CTMX 3
  • NNDM 0
  • Target Price
  • CTMX $5.67
  • NNDM N/A
  • AVG Volume (30 Days)
  • CTMX 4.1M
  • NNDM 1.4M
  • Earning Date
  • CTMX 11-06-2025
  • NNDM 09-05-2025
  • Dividend Yield
  • CTMX N/A
  • NNDM N/A
  • EPS Growth
  • CTMX 263.20
  • NNDM N/A
  • EPS
  • CTMX 0.49
  • NNDM N/A
  • Revenue
  • CTMX $141,100,000.00
  • NNDM $58,812,000.00
  • Revenue This Year
  • CTMX N/A
  • NNDM N/A
  • Revenue Next Year
  • CTMX N/A
  • NNDM N/A
  • P/E Ratio
  • CTMX $4.66
  • NNDM N/A
  • Revenue Growth
  • CTMX 18.01
  • NNDM 7.49
  • 52 Week Low
  • CTMX $0.40
  • NNDM $1.31
  • 52 Week High
  • CTMX $3.10
  • NNDM $2.74
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 49.61
  • NNDM 48.14
  • Support Level
  • CTMX $2.02
  • NNDM $1.32
  • Resistance Level
  • CTMX $2.17
  • NNDM $1.40
  • Average True Range (ATR)
  • CTMX 0.14
  • NNDM 0.05
  • MACD
  • CTMX 0.03
  • NNDM 0.00
  • Stochastic Oscillator
  • CTMX 55.42
  • NNDM 46.98

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

Share on Social Networks: